Trials / Completed
CompletedNCT04616976
COVID-19 With Convalescent Plasma
Efficiency of Convalescent Plasma Therapy in Management of Critically Ill Patients With COVID-19: a Matched Case-control Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 78 (actual)
- Sponsor
- Southeast University, China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To clarify the effects of convalescent plasma therapy on SARS-CoV-2 negative conversion rate during hospital stay and 28-day mortality of severe and life-threatening COVID-19 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | convalescent plasma | convalescent plasma was get from the patients who recovery from COVID-19 |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-02-29
- Completion
- 2020-11-01
- First posted
- 2020-11-05
- Last updated
- 2020-11-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04616976. Inclusion in this directory is not an endorsement.